1. Home
  2. INLX vs ATNM Comparison

INLX vs ATNM Comparison

Compare INLX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • ATNM
  • Stock Information
  • Founded
  • INLX 1996
  • ATNM 2000
  • Country
  • INLX United States
  • ATNM United States
  • Employees
  • INLX N/A
  • ATNM N/A
  • Industry
  • INLX EDP Services
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • ATNM Health Care
  • Exchange
  • INLX Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • INLX 40.8M
  • ATNM 49.0M
  • IPO Year
  • INLX N/A
  • ATNM N/A
  • Fundamental
  • Price
  • INLX $9.87
  • ATNM $1.76
  • Analyst Decision
  • INLX
  • ATNM Strong Buy
  • Analyst Count
  • INLX 0
  • ATNM 2
  • Target Price
  • INLX N/A
  • ATNM $4.50
  • AVG Volume (30 Days)
  • INLX 2.3K
  • ATNM 165.2K
  • Earning Date
  • INLX 08-13-2025
  • ATNM 08-08-2025
  • Dividend Yield
  • INLX N/A
  • ATNM N/A
  • EPS Growth
  • INLX N/A
  • ATNM N/A
  • EPS
  • INLX N/A
  • ATNM N/A
  • Revenue
  • INLX $17,127,854.00
  • ATNM N/A
  • Revenue This Year
  • INLX $2.47
  • ATNM N/A
  • Revenue Next Year
  • INLX $7.72
  • ATNM N/A
  • P/E Ratio
  • INLX N/A
  • ATNM N/A
  • Revenue Growth
  • INLX N/A
  • ATNM N/A
  • 52 Week Low
  • INLX $8.74
  • ATNM $1.03
  • 52 Week High
  • INLX $16.50
  • ATNM $2.41
  • Technical
  • Relative Strength Index (RSI)
  • INLX 38.26
  • ATNM 58.77
  • Support Level
  • INLX $8.98
  • ATNM $1.66
  • Resistance Level
  • INLX $10.17
  • ATNM $1.81
  • Average True Range (ATR)
  • INLX 0.42
  • ATNM 0.11
  • MACD
  • INLX 0.01
  • ATNM 0.02
  • Stochastic Oscillator
  • INLX 40.16
  • ATNM 89.78

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: